PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer.

Details

Language :

English

ISSN :

2523-3548

Volume :

45

Issue :

1

Database :

MEDLINE

Journal :

Cancer communications (London, England)

Publication Type :

Editorial & Opinion

Accession number :

39582148

Full Text :

https://doi.org/10.1002/cac2.12632